Zobrazeno 1 - 10
of 24
pro vyhledávání: '"B. Shropshire"'
Autor:
Kristin M. Zersen, Angela Molli, Brooke G. Weisbeck, Samantha Fedotova, Jessica M. Quimby, Daniel L. Gustafson, Sarah B. Shropshire
Publikováno v:
Veterinary Sciences, Vol 11, Iss 3, p 112 (2024)
The purpose of this study was to evaluate plasma ondansetron (OND) concentrations in a population of dogs with naturally occurring nausea after oral OND administration. Twenty-four dogs were randomly assigned to receive one of the following doses of
Externí odkaz:
https://doaj.org/article/b0f3dda08606495f9d697c7769931568
Publikováno v:
Journal of Veterinary Internal Medicine, Vol 35, Iss 2, Pp 892-901 (2021)
Abstract Background Coagulation status is poorly understood in dogs with chronic inflammatory enteropathy (CIE). Fibrinolytic activity and platelet dynamics have not been evaluated in CIE dogs. Objectives To assess coagulation status and fibrinolysis
Externí odkaz:
https://doaj.org/article/bc0b88d6e8294a8bbf685c5ab045d1c1
Publikováno v:
Journal of Veterinary Internal Medicine, Vol 34, Iss 3, Pp 1214-1221 (2020)
Abstract Background Concerns for recrudescence of Ehrlichia canis infection arise when immunosuppressive drugs are used to treat immune‐mediated diseases in dogs previously infected with E. canis. Objectives Determine whether administration of pred
Externí odkaz:
https://doaj.org/article/08cdbde262eb4bd8a69e0bf47b450b70
Publikováno v:
Journal of Feline Medicine and Surgery. 24:e394-e400
Objectives Hyperthyroidism frequently affects middle-to-older-aged cats that can present with cardiorespiratory signs. The effects of hyperthyroidism on cardiac size and function have been previously documented. Anecdotally, pulmonary hyperinflation
Autor:
Cindy K. Sotelo, Sarah B. Shropshire, Jessica Quimby, Sydney Simpson, Daniel L. Gustafson, Kristin M. Zersen
Publikováno v:
Journal of Veterinary Pharmacology and Therapeutics. 45:508-515
The purpose of this study was to evaluate the pharmacokinetics of intravenous (IV) ondansetron in a population of hospitalized dogs exhibiting clinical signs of nausea. The causes of nausea included pancreatitis, gastroenteritis, endocarditis, chemot
Publikováno v:
Journal of Veterinary Internal Medicine
Journal of Veterinary Internal Medicine, Vol 35, Iss 2, Pp 892-901 (2021)
Journal of Veterinary Internal Medicine, Vol 35, Iss 2, Pp 892-901 (2021)
Background Coagulation status is poorly understood in dogs with chronic inflammatory enteropathy (CIE). Fibrinolytic activity and platelet dynamics have not been evaluated in CIE dogs. Objectives To assess coagulation status and fibrinolysis in normo
Publikováno v:
Journal of Feline Medicine and Surgery. 23:715-721
Objectives The aims of this study were to determine if stable chronic kidney disease (CKD) cats and uremic crisis cats have altered platelet function, and to determine the prevalence of positive fecal occult blood in CKD cats. Methods Platelet functi
Publikováno v:
Journal of Veterinary Internal Medicine, Vol 34, Iss 3, Pp 1214-1221 (2020)
Journal of Veterinary Internal Medicine
Journal of Veterinary Internal Medicine
Background Concerns for recrudescence of Ehrlichia canis infection arise when immunosuppressive drugs are used to treat immune-mediated diseases in dogs previously infected with E. canis. Objectives Determine whether administration of prednisolone an
Publikováno v:
Journal of Veterinary Internal Medicine, Vol 34, Iss 2, Pp 710-718 (2020)
Journal of Veterinary Internal Medicine
Journal of Veterinary Internal Medicine
Background Dogs with protein-losing nephropathy (PLN) are treated with antiplatelet drugs for thromboprophylaxis but no standardized method exists to measure drug response. It is also unknown if clopidogrel metabolite concentrations [CM] differ betwe
Publikováno v:
Journal of Veterinary Internal Medicine
Journal of Veterinary Internal Medicine, Vol 34, Iss 2, Pp 700-709 (2020)
Journal of Veterinary Internal Medicine, Vol 34, Iss 2, Pp 700-709 (2020)
Background Antiplatelet antibodies are detected in multiple diseases including primary immune thrombocytopenia (ITP). Dynamics of how these antibodies change over time in ITP is unknown in dogs. Hypothesis/Objectives Antiplatelet antibodies (APA) wil